Skip to main content

Severe Pain News

FDA Approves Targiniq ER Extended-Release Oxycodone with Abuse-Deterrent Properties

July 23, 2014 – Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting...

Ask a question

To post your own question to this support group, sign in or create an account.